Nadeem Riaz directs the Precision Radiotherapy Initiative and leads a multidisciplinary research lab at the intersection of the DNA damage response and anti-tumor immunity. He talks us through his important paper examining mechanisms of resistance and some of the pitfalls of academia.

Yungan Tao President-Elect GORTEC, and Radiation Oncologist in Head and Neck cancer at Institut Gustave-Roussy talks us through the NICOPOSTOP trial. Will risks diplomatic incidents and out European tour continues.

The Danish Head and Neck Cancer (DAHANCA) group was established in 1976 as a working group by the Danish Society for Head and Neck Oncology. Since it has gone from strength to strength and continues to pioneer cooperative group research on a national scale! Current head Jeppe Friborg talks us through their up and coming work.

Den danske gruppe for hoved- og halskræft (DAHANCA) blev etableret i 1976 som en arbejdsgruppe under Dansk Selskab for Hoved- og Halsonkologi. Siden da er gruppen gået fra styrke til styrke og fortsætter med at være pionerer inden for kooperativ gruppeforskning på nationalt plan! Nuværende leder, Jeppe Friborg, fortæller os om deres kommende arbejde.

Pierre Blanchard, Professor at Gustave Roussy and Editor of Radiotherapy and Oncology 'the green journal' joins us to discuss his recent trial

Professor and Vice-chair of Hematology and Medical Oncology, and Professor of Otolaryngology at the Winship Cancer Institute at the Emory University School of Medicine in Atlanta, Georgia. He talks us through sinonasal histologies . Ben refers Will to social services.

Superstar Kate Hutcheson, Professor in the  Department of Head and Neck Surgery at The University of Texas MD Anderson  Cancer Center. and Director of Speech Pathology and Audiology talks to us about long term outcomes and examines Will's literacy.

We're back with Chris Holsinger for part 2 of the TORS adventure

Chris Holsinger from Stanford gets grilled by Ben and Will on TORS history in this part 1/2 episode.

We talk ORATOR, ORATOR 2 and the genesis of evidence in TORS!

Melvin Chua joins the deeply marginal crowd to talk EBV ctDNA, its clinical use, science, gardening and islands.